Regulatory Record: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

FDA action counts

Enforcement history

On 2025-01-06, Argus HQ recorded an FDA Form 483 inspection citation for Suzhou Suncadia Biopharmaceuticals Co., Ltd., rated "high" severity in Argus HQ's classification: Suzhou Suncadia Biopharmaceuticals Co., Ltd. -- FDA 483: 3 observations (2025-01-06). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Suzhou Suncadia Biopharmaceuticals Co., Ltd. has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Frequently asked questions

What is the most recent FDA action against Suzhou Suncadia Biopharmaceuticals Co., Ltd.?

The most recent FDA event Argus HQ has on file for Suzhou Suncadia Biopharmaceuticals Co., Ltd. is dated 2025-01-06, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Does Argus HQ track new FDA actions for Suzhou Suncadia Biopharmaceuticals Co., Ltd. automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Suzhou Suncadia Biopharmaceuticals Co., Ltd. is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Suzhou Suncadia Biopharmaceuticals Co., Ltd.?

1 total: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.

What is the most recent FDA action on file for Suzhou Suncadia Biopharmaceuticals Co., Ltd.?

January 6, 2025. Argus HQ ingests new FDA enforcement records daily.

Related enforcement actions

• Suzhou Suncadia Biopharmaceuticals Co., Ltd. -- FDA 483: 3 observations (2025-01-06) →

Compare with

• Suzhou Suncadia Biopharmaceuticals Co., Ltd. vs Medline Industries, LP
• Suzhou Suncadia Biopharmaceuticals Co., Ltd. vs ARROW INTERNATIONAL, LLC
• Suzhou Suncadia Biopharmaceuticals Co., Ltd. vs Stryker Sustainability Solutions
• Suzhou Suncadia Biopharmaceuticals Co., Ltd. vs Guardian Drug Co. Inc.
• Suzhou Suncadia Biopharmaceuticals Co., Ltd. vs B BRAUN MEDICAL INC